Skip to main content

Your search for “pharmaceuticals” returned 592 results

Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD

August 23, 2023

$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.

UC San Diego Health: Excellence in Medication Safety, Pharmacy Practice

February 17, 2022

UC San Diego Health has become the first organization recognized as a Certified Center of Excellence in Medication-Use Safety and Pharmacy Practice by the American Society of Health-System Pharmacists.

Headline News: Botox Injections May Lessen Depression

July 30, 2020

By analyzing the FDA database of adverse drug effects, UC San Diego researchers discovered that people who received Botox injections — not just in the forehead — reported depression significantly less often than patients undergoing different treatments for the same conditions.

Researchers Develop New Tools to Optimize CHO Cell Lines for Making Biologic Drugs

April 13, 2017

Chinese hamster ovary (CHO) cells are the workhorses behind more than half of the top-selling biologics on the market today. Humira, Avastin and Rituxan are a few. Researchers at the UC San Diego CHO Systems Biology Center are developing new tools, such as genome-scale metabolic models, to optimize CHO cell…

CHO Systems Biology Center Pioneers Efforts to Improve Cell Production of High-Value Pharmaceuticals

April 13, 2017

Optimizing CHO (Chinese hamster ovary) cell lines to accelerate biologic drug development is a goal of the CHO Systems Biology Center at the University of California San Diego Jacobs School of Engineering. Center researchers are developing new technologies and training the next generation of cell line engineers and systems biology…

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

October 31, 2022

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.

Novel Imaging Model Helps Reveal New Therapeutic Target for Pancreatic Cancer

June 6, 2016

…at Keio University, the University of Nebraska and Ionis Pharmaceuticals describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target.

How Gene Therapy May Hold Key to Treating Life-Threatening Cardiac Disease

March 18, 2020

New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.

NIH Helps UC San Diego Researchers Repurpose Sanofi Pain Drug for Tropical Disease

July 27, 2015

The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), has awarded James McKerrow, MD, PhD, dean of the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, with a 2015 New Therapeutic Uses Award.

Study: Medications Alone Don’t Help Smokers Quit

December 20, 2017

Pharmaceutical interventions are routinely prescribed to help people quit smoking. However, a new study by University of California San Diego School of Medicine researchers suggests that, despite promising results in clinical trials, smoking cessation drugs alone may not be improving the chances of successful quitting among smokers in general.

Category navigation with Social links